EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair

Emily Y Fan, Andres Schanzer, Adam W Beck, Matthew J Eagleton, Mark A Farber, Warren J Gasper, W Anthony Lee, Gustavo S Oderich, F Ezequiel Parodi, Darren B Schneider, Matthew P Sweet, Carlos H Timaran und 2 weitere

Journal of Vascular Surgery · 2024-10 · 80 (4) · 968-978.e3

DOI: 10.1016/j.jvs.2024.05.041 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2024-10. Verfasst von Emily Y Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Massachusetts, Worcester, MA. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Endovascular Procedures, Anticoagulants, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Antiplatelet and/or anticoagulant therapy are commonly prescribed after fenestrated/branched endovascular aortic repair (F/BEVAR). However, the optimal regimen remains unknown. We sought to characterize practice patterns and outcomes of antiplatelet and anticoagulant use in patients who underwent F/BEVAR. METHODS: Consecutive patients enrolled (2012-2023) as part of the United States Aortic Research Consortium (US-ARC) from 10 independent physician-sponsored investigational device exemption studies were evaluated. The cohort was characterized by medication regimen on discharge from index F/BEVAR: (1) Aspirin alone OR P2Y12 alone (single-antiplatelet therapy [SAPT]); (2) Anticoagulant alone; (3) Aspirin + P2Y12 (dual-antiplatelet therapy [DAPT]); (4) Aspirin + anticoagulant OR P2Y12 + anticoagulant (SAPT + anticoagulant); (5) Aspirin + P2Y12 + anticoagulant (triple therapy [TT]); and (6) No therapy. Kaplan-Meier analysis and Cox proportional hazards modeling were used to compare 1-year outcomes including survival, target artery patency, freedom from bleeding complication, freedom from all reinterventions, and freedom from stent-specific reintervention. RESULTS: Of the 1525 patients with complete exposure and outcome data, 49.6% were discharged on DAPT, 28.8% on SAPT, 13.6% on SAPT + anticoagulant, 3.2% on TT, 2.6% on anticoagulant alone, and 2.2% on no therapy. Discharge medication regimen was not associated with differences in 1-year survival, bleeding complications, composite reintervention rate, or stent-specific reintervention rate. However, there was a significant difference in 1-year target artery patency. On multivariable analysis comparing with SAPT, DAPT conferred a lower hazard of loss of target artery patency (hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.27-0.84; P = .01). On sub-analyses of renal stents alone or visceral stents alone, DAPT no longer had a significantly lower hazard of loss of target artery patency (renal: HR, 0.66; 95% CI, 0.35-1.27; P = .22; visceral: HR, 0.31; 95% CI, 0.05-1.9; P = .21). Lastly, duration of DAPT therapy (1 month, 6 months, or 1 year) did not significantly affect target artery patency. CONCLUSIONS: Practice patterns for antiplatelet and anticoagulant regimens after F/BEVAR vary widely across the US-ARC. There were no differences in bleeding complications, survival or reintervention rates among different regimens, but higher branch vessel patency was noted in the DAPT cohort. These data suggest there is a benefit in DAPT therapy. However, the generalizability of this finding is limited by the retrospective nature of this data, and the clinical significance of this finding is unclear, as there is no difference in survival, bleeding, or reintervention rates amongst the different regimens. Hence, an "optimal" regimen, including the duration of such regimen, could not be clearly discerned. This suggests equipoise for a randomized trial, nested within this cohort, to identify the most effective antiplatelet/anticoagulant regimen for the growing number of patients being treated globally with F/BEVAR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsEndovascular ProceduresAnticoagulantsBlood Vessel Prosthesis ImplantationPractice Patterns, Physicians'HumansFemaleMaleAgedTreatment OutcomeTime FactorsRetrospective StudiesAged, 80 and overRisk FactorsUnited StatesStentsDual Anti-Platelet TherapyRisk AssessmentMiddle AgedAspirinVascular PatencyBlood Vessel ProsthesisDrug Therapy, CombinationEndovascular Aneurysm Repair

Stichwörter der Autor:innen

AnticoagulantAntiplateletDual antiplateletFEVARFenestrated/branched endovascular aortic repairNESVS 2023Thoracoabdominal aortic aneurysm

Substanzen

Platelet Aggregation InhibitorsAnticoagulantsAspirin

Autor:innen und Institutionen

  • University of Massachusetts, Worcester, MA.
  • University of Alabama, Birmingham, AL.
  • Massachusetts General Hospital, Boston, MA.
  • University of North Carolina, Chapel Hill, NC.
  • University of California San Francisco, San Francisco, CA.
  • Baptist Health, Boca Raton, FL.

Zitieren

APA

Fan, E. Y., Schanzer, A., Beck, A. W., Eagleton, M. J., Farber, M. A., Gasper, W. J., Lee, W. A., Oderich, G. S., Parodi, F. E., Schneider, D. B., Sweet, M. P., Timaran, C. H., Simons, J. P., & US Aortic Research Consortium (2024). Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair. Journal of Vascular Surgery, 80(4), 968-978.e3. https://doi.org/10.1016/j.jvs.2024.05.041

Vancouver

Fan EY, Schanzer A, Beck AW, Eagleton MJ, Farber MA, Gasper WJ, et al. Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair. Journal of Vascular Surgery. 2024;80(4):968-978.e3. doi:10.1016/j.jvs.2024.05.041

BibTeX
@article{Fan2024,
  author = {Fan, Emily Y and Schanzer, Andres and Beck, Adam W and Eagleton, Matthew J and Farber, Mark A and Gasper, Warren J and Lee, W Anthony and Oderich, Gustavo S and Parodi, F Ezequiel and Schneider, Darren B and Sweet, Matthew P and Timaran, Carlos H and Simons, Jessica P and US Aortic Research Consortium, US Aortic Research Consortium},
  title = {Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  volume = {80},
  number = {4},
  pages = {968--978.e3},
  doi = {10.1016/j.jvs.2024.05.041}
}
Kostenlos starten →